The SenoScan2 slot scanning digital mammography (SSDM) system from Fischer Imaging is being introduced at the RSNA meeting. Fischer designs, manufactures, and markets medical imaging systems for screening and diagnosis.
The SenoScan2 slot scanning digital mammography (SSDM) system from Fischer Imaging is being introduced at the RSNA meeting. Fischer designs, manufactures, and markets medical imaging systems for screening and diagnosis.
The system mixes high image resolution and reduced radiation dose, while virtually eliminating motion artifacts, according to the company. Fischer calls it the next generation of slot scanning technology and claims SenoScan2 is the only digital mammography unit to offer both 50- and 25-micron native diagnostic resolution.
SenoScan2 will be included in a three-year global agreement signed last month with Philips Medical Systems. Under terms of the agreement, Philips will sell, service, and support a specialized version of Fischer's digital mammography system integrated with Philips' image processing and user interface.
"The SenoScan2 enables users to fully maximize image quality with customizable workflow and image management capabilities in a series of robust workstations that will scale to their needs," said Harris Ravine, president and CEO of Fischer. "The partnership with Philips will dramatically expand access to powerful end-to-end digital mammography solutions."
Fischer's slot scanning technology uses a tightly collimated x-ray beam that scans in precise alignment with a narrow slotted image receptor. The design essentially eliminates the negative effects of scatter radiation without requiring the use of a grid. The result is sharp, high-resolution images with up to a 60% reduction in radiation dose, according to the company.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
Radiology Experience, Breast Density and Screening Mammography: What New Research Reveals
October 4th 2024In a study looking at the impact of experience and case volume of breast screening radiologists, researchers found that reviewing more than 150 cases per week was necessary to achieve an 80 percent rate of true-positive assessments for malignant calcifications.